Synvisc shortage update: What patients need to know in 2026

Updated:

March 12, 2026

Author:

Peter Daggett

Summarize this blog with AI:

Latest updates on Synvisc availability in 2026. Learn about current supply status, pricing changes, and alternative options for knee osteoarthritis.

The current state of Synvisc availability in 2026

If you've been prescribed Synvisc for knee osteoarthritis, you might be wondering about recent availability concerns. Let's cut through the confusion and give you the facts about what's really happening with Synvisc supply in 2026.

Is Synvisc still in shortage?

Good news first: There is no widespread Synvisc shortage in 2026. Sanofi continues to manufacture both Synvisc and Synvisc-One, and the products are available through normal distribution channels.

The reality: What many patients experience as a "shortage" is actually a complex distribution and access issue. Here's what's really happening:

  • Selective stocking: Many practices choose not to keep Synvisc in regular inventory due to cost and storage requirements
  • Insurance barriers: Prior authorization requirements create delays that feel like supply issues
  • Specialty distribution: Unlike regular medications, Synvisc requires specialty pharmacy networks
  • Regional variations: Some areas have better access than others based on provider density

Why Synvisc feels hard to find

It's not a supply problem—it's an access problem

The challenges patients face finding Synvisc aren't due to manufacturing shortages. Instead, they stem from:

High practice costs: Each vial costs $600-$1,200, making it expensive for practices to stock "just in case."

Expiration concerns: Unopened Synvisc has a limited shelf life, and practices can't afford to let expensive inventory expire.

Insurance unpredictability: Practices may be reluctant to stock medications when insurance approval is uncertain.

Specialized administration: Only certain medical specialties routinely provide viscosupplement injections.

COVID-19's lingering impact

While we're well past the acute phase of the pandemic, some effects on medical practice operations persist:

  • Many practices streamlined their inventory to essential items only
  • Patient volume changes affected ordering patterns
  • Telehealth growth means fewer in-office procedures
  • Supply chain caution has made practices more conservative with specialty medications

What's changed with Synvisc costs in 2026

Price increases: Like many specialty medications, Synvisc costs have risen with inflation. Current cash prices range:

  • Synvisc (3-injection series): $1,800-$3,600 for the complete series
  • Synvisc-One (single injection): $800-$1,400 per injection
  • Additional costs: $100-$300 for imaging guidance, $75-$200 for office visit fees

Insurance coverage changes: Some plans have:

  • Added step therapy requirements
  • Increased copays for specialty injections
  • Shifted coverage to preferred alternatives
  • Required more extensive prior authorization documentation

Good news: Medicare coverage remains stable, and most major insurance plans continue to cover Synvisc when medical necessity criteria are met.

New options available in 2026

The viscosupplement landscape has expanded, giving patients more choices:

Established alternatives

  • Hyalgan: 5-injection series, often better insurance coverage
  • Euflexxa: 3-injection series, non-avian source (good for allergy concerns)
  • Orthovisc: 3-injection series, high molecular weight
  • Gel-One: Single injection, cost-effective option

Newer viscosupplement options

  • Monovisc: Single injection with extended relief
  • Durolane: Single injection, up to 6 months of relief
  • TriVisc: 3-injection alternative with competitive pricing

Many of these alternatives are more readily available than Synvisc and may offer similar benefits with different cost structures.

How to find Synvisc in stock today

Use targeted search tools: Medfinder specializes in locating hard-to-find medications and can help you identify practices with current Synvisc inventory.

Focus on high-volume practices:

  • University medical centers
  • Large orthopedic groups
  • Specialized arthritis centers
  • Sports medicine clinics

Ask about ordering policies: Many practices will order Synvisc specifically for confirmed patients with insurance approval.

Consider specialty pharmacy partnerships: Some practices work with specialty pharmacies to ensure medication availability for scheduled appointments.

What to do if you can't wait

If you need immediate relief and can't locate Synvisc quickly:

Discuss alternatives with your doctor: Several effective alternatives may be more readily available.

Consider corticosteroid bridge therapy: While waiting for Synvisc availability, steroid injections can provide temporary relief.

Explore other pain management options:

  • Physical therapy intensification
  • Topical anti-inflammatory treatments
  • Oral medications for temporary relief
  • Activity modification strategies

Looking ahead: what to expect

Supply stability: Sanofi has not announced any production changes for Synvisc, and supply should remain stable throughout 2026.

Competition benefits: With more viscosupplement options available, competition should help with both pricing and availability.

Access improvements: Healthcare systems are adapting to better manage specialty medications, which should improve patient access over time.

Insurance evolution: As viscosupplements become more established, insurance coverage policies are stabilizing.

Practical next steps

If you need Synvisc treatment:

  1. Get insurance pre-authorization started early (allow 2-3 weeks)
  2. Use Medfinder to locate available providers
  3. Ask your doctor about alternatives if Synvisc isn't readily available
  4. Consider timing flexibility to work around practice ordering schedules
  5. Explore patient assistance programs if cost is a concern

The bottom line

While Synvisc isn't technically in shortage, access challenges are real and frustrating for patients. The good news is that these are solvable problems with the right approach and information.

Don't let availability concerns delay your treatment. Whether you end up with Synvisc or an effective alternative, the goal is the same: reducing your knee pain and improving your quality of life.

For more detailed guidance on locating Synvisc, check out our comprehensive guide on how to find Synvisc in stock near you.

Remember, millions of people successfully receive viscosupplement treatments every year. With persistence and the right strategy, you can too.

Is there an actual Synvisc shortage in 2026?

No, there is no manufacturing shortage of Synvisc in 2026. Sanofi continues normal production. The challenges patients face are related to distribution, practice inventory management, and insurance access issues, not supply shortages from the manufacturer.

Why do some doctors say they "can't get" Synvisc?

When doctors say they "can't get" Synvisc, they usually mean they don't keep it in regular stock due to cost ($600-$1,200 per vial) and storage requirements. Most can order it for specific patients with confirmed insurance approval, but it requires advance planning.

Has Synvisc become more expensive in 2026?

Yes, like most specialty medications, Synvisc prices have increased with inflation. Synvisc-One now costs $800-$1,400 per injection (up from $600-$1,200 in previous years), plus additional fees for office visits and imaging guidance if needed.

Should I switch to an alternative or wait to find Synvisc?

This depends on your pain level and urgency. If you're in significant pain, alternatives like Hyalgan, Euflexxa, or Orthovisc are proven effective and often more readily available. If your pain is manageable and you prefer Synvisc specifically, it's usually worth spending 2-3 weeks to locate it through proper channels.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy